2026 Q1 -tulosraportti
Vain PDF
77 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 päivä sittenStock status Privatrezept from 2 to 3 pharmacies that have Weeco Astrum10-10 in stock. Privatrezept primarily sells to private addresses, but also has a collaboration with these three pharmacies, which they also send to, and which have the oil in stock. It is very clear to see that sales in Germany are accelerating, and I have bought many shares in this company, precisely because I have seen, and have shared with you here on Nordnet Social, that many prescriptions are being handed over the counter, and that this has already started in Q2. When we know that, the management also knows it, and if PJ and TS choose first to disclose this to the market, that there has been a much larger sale in Germany than they have announced, at least 3 times, and/or they adjust the financial statements for the entire 2026, on August 20th, then I believe they have violated their disclosure obligation, and I will find an authority that will investigate if this is the case, and that their previous statements are the reason why the share price is at rock bottom.
Previously you stated that Stenocare had announced that they expected 0kr in revenue from Germany in 2026. Now I can read that you have corrected this to "maybe a little sales in 2026". You yourself say that sales have EXPLODED in Germany, and accuse the management of Stenocare of deliberately withholding this information. It's going to be a damn exciting Q2 report :)- ·2 päivää sitten · MuokattuAn announcement has been issued today, regarding legislation that was just adopted in July. Source from Bundesrat, In the top sections it states that it is not entirely clarified with regard to the people who are undergoing treatment with flower medicine. A little further down you can read that the pharmacies have already anticipated the law change and have sent out letters about the upcoming law change. That is naturally why yesterday we could ascertain that several pharmacies have received Weeco Astrum 10/10 in stock. see under the heading : Current information from health practice https://bdcan.de/cannabisblueten-gkv/
- ·3 päivää sittenI have inserted this article, because here it states, in black and white, that those persons who today receive flower medicine, can get a prescription immediately, for cannabis oils. They are not included in the 6-month quarantine. That is also why we can already see that doctors have started to prescribe cannabis oils. There are only 5 months until the subsidy for flower medicine stops. Therefore, I expect that the cannabis shops that only have flowers in their assortment will start to get oils. If you don't want to spend time reading the entire article, you can just read what Dr. Christiane Neubaur, managing director of Verband der Cannabis versorgenden Apotheken (VCA) has said about the above. Dr. Christiane Neubaur, managing director of Verband der Cannabis versorgenden Apotheken (VCA), wrote on LinkedIn: "Many patients who currently receive prescription cannabis medicine do not fall under these approved indications." https://cannabishealthnews.co.uk/2026/07/14/germany-bans-medical-cannabis-flower-from-reimbursement-and-mandates-six-month-trial-for-extracts/I repeat again, again and gladly do it again. The people who have been in a treatment course with Cannabis flowers are beyond the 6 months because they HAVE been in a treatment course with cannabis flowers. The people who have received a prescription for cannabis flowers, but who are not documented as ill, they lose the subsidy and must pay themselves. The people who will be affected, i.e., that they have to wait 6 months before they can get a prescription for ex. Weeco Astrum 10/10, are those who are just entering the treatment system now. Everyone else who has been in treatment systems has completed the 6-month quarantine. The above is the direct reason why we can state today that several pharmacies have received Weeco Astrum 10/10 in stock. As well as we will also see online stores that currently only have flower medicine in their assortment also getting oils and extracts. Either you can scroll down and read what I have written about spin and that it's not about people losing their subsidy. It's only about many people losing a lot of money because flower medicine loses the subsidy, or you can start digging yourself into what is actually happening in Germany.
- ·3 päivää sittenStock status Can One Stop has gone from 3 to 5 pharmacies that have Weeco Astrum 10/10 permanently in stock. They still send to the remaining pharmacies, 519 pharmacies, with which they have a collaboration. Green Medical has gone from 3 to 5 pharmacies. Green Medical sends to these 5 pharmacies and to private addresses. Weed.de has gone from 3 to 7 pharmacies Weed.de also sends to private addresses. Canngo has gone from 4 to 6 pharmacies Canngo also sends the oil to private addresses. Flowzz has gone from 3 to 5 pharmacies. Flowzz also sends the oil to private addresses. It seems that Weeco Pharma's campaign for Weeco Astrum 10/10 is working. As well as that doctors also, gradually, have started to find alternatives to flower medicine.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
77 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenStock status Privatrezept from 2 to 3 pharmacies that have Weeco Astrum10-10 in stock. Privatrezept primarily sells to private addresses, but also has a collaboration with these three pharmacies, which they also send to, and which have the oil in stock. It is very clear to see that sales in Germany are accelerating, and I have bought many shares in this company, precisely because I have seen, and have shared with you here on Nordnet Social, that many prescriptions are being handed over the counter, and that this has already started in Q2. When we know that, the management also knows it, and if PJ and TS choose first to disclose this to the market, that there has been a much larger sale in Germany than they have announced, at least 3 times, and/or they adjust the financial statements for the entire 2026, on August 20th, then I believe they have violated their disclosure obligation, and I will find an authority that will investigate if this is the case, and that their previous statements are the reason why the share price is at rock bottom.Previously you stated that Stenocare had announced that they expected 0kr in revenue from Germany in 2026. Now I can read that you have corrected this to "maybe a little sales in 2026". You yourself say that sales have EXPLODED in Germany, and accuse the management of Stenocare of deliberately withholding this information. It's going to be a damn exciting Q2 report :)
- ·2 päivää sitten · MuokattuAn announcement has been issued today, regarding legislation that was just adopted in July. Source from Bundesrat, In the top sections it states that it is not entirely clarified with regard to the people who are undergoing treatment with flower medicine. A little further down you can read that the pharmacies have already anticipated the law change and have sent out letters about the upcoming law change. That is naturally why yesterday we could ascertain that several pharmacies have received Weeco Astrum 10/10 in stock. see under the heading : Current information from health practice https://bdcan.de/cannabisblueten-gkv/
- ·3 päivää sittenI have inserted this article, because here it states, in black and white, that those persons who today receive flower medicine, can get a prescription immediately, for cannabis oils. They are not included in the 6-month quarantine. That is also why we can already see that doctors have started to prescribe cannabis oils. There are only 5 months until the subsidy for flower medicine stops. Therefore, I expect that the cannabis shops that only have flowers in their assortment will start to get oils. If you don't want to spend time reading the entire article, you can just read what Dr. Christiane Neubaur, managing director of Verband der Cannabis versorgenden Apotheken (VCA) has said about the above. Dr. Christiane Neubaur, managing director of Verband der Cannabis versorgenden Apotheken (VCA), wrote on LinkedIn: "Many patients who currently receive prescription cannabis medicine do not fall under these approved indications." https://cannabishealthnews.co.uk/2026/07/14/germany-bans-medical-cannabis-flower-from-reimbursement-and-mandates-six-month-trial-for-extracts/I repeat again, again and gladly do it again. The people who have been in a treatment course with Cannabis flowers are beyond the 6 months because they HAVE been in a treatment course with cannabis flowers. The people who have received a prescription for cannabis flowers, but who are not documented as ill, they lose the subsidy and must pay themselves. The people who will be affected, i.e., that they have to wait 6 months before they can get a prescription for ex. Weeco Astrum 10/10, are those who are just entering the treatment system now. Everyone else who has been in treatment systems has completed the 6-month quarantine. The above is the direct reason why we can state today that several pharmacies have received Weeco Astrum 10/10 in stock. As well as we will also see online stores that currently only have flower medicine in their assortment also getting oils and extracts. Either you can scroll down and read what I have written about spin and that it's not about people losing their subsidy. It's only about many people losing a lot of money because flower medicine loses the subsidy, or you can start digging yourself into what is actually happening in Germany.
- ·3 päivää sittenStock status Can One Stop has gone from 3 to 5 pharmacies that have Weeco Astrum 10/10 permanently in stock. They still send to the remaining pharmacies, 519 pharmacies, with which they have a collaboration. Green Medical has gone from 3 to 5 pharmacies. Green Medical sends to these 5 pharmacies and to private addresses. Weed.de has gone from 3 to 7 pharmacies Weed.de also sends to private addresses. Canngo has gone from 4 to 6 pharmacies Canngo also sends the oil to private addresses. Flowzz has gone from 3 to 5 pharmacies. Flowzz also sends the oil to private addresses. It seems that Weeco Pharma's campaign for Weeco Astrum 10/10 is working. As well as that doctors also, gradually, have started to find alternatives to flower medicine.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
77 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 päivä sittenStock status Privatrezept from 2 to 3 pharmacies that have Weeco Astrum10-10 in stock. Privatrezept primarily sells to private addresses, but also has a collaboration with these three pharmacies, which they also send to, and which have the oil in stock. It is very clear to see that sales in Germany are accelerating, and I have bought many shares in this company, precisely because I have seen, and have shared with you here on Nordnet Social, that many prescriptions are being handed over the counter, and that this has already started in Q2. When we know that, the management also knows it, and if PJ and TS choose first to disclose this to the market, that there has been a much larger sale in Germany than they have announced, at least 3 times, and/or they adjust the financial statements for the entire 2026, on August 20th, then I believe they have violated their disclosure obligation, and I will find an authority that will investigate if this is the case, and that their previous statements are the reason why the share price is at rock bottom.Previously you stated that Stenocare had announced that they expected 0kr in revenue from Germany in 2026. Now I can read that you have corrected this to "maybe a little sales in 2026". You yourself say that sales have EXPLODED in Germany, and accuse the management of Stenocare of deliberately withholding this information. It's going to be a damn exciting Q2 report :)
- ·2 päivää sitten · MuokattuAn announcement has been issued today, regarding legislation that was just adopted in July. Source from Bundesrat, In the top sections it states that it is not entirely clarified with regard to the people who are undergoing treatment with flower medicine. A little further down you can read that the pharmacies have already anticipated the law change and have sent out letters about the upcoming law change. That is naturally why yesterday we could ascertain that several pharmacies have received Weeco Astrum 10/10 in stock. see under the heading : Current information from health practice https://bdcan.de/cannabisblueten-gkv/
- ·3 päivää sittenI have inserted this article, because here it states, in black and white, that those persons who today receive flower medicine, can get a prescription immediately, for cannabis oils. They are not included in the 6-month quarantine. That is also why we can already see that doctors have started to prescribe cannabis oils. There are only 5 months until the subsidy for flower medicine stops. Therefore, I expect that the cannabis shops that only have flowers in their assortment will start to get oils. If you don't want to spend time reading the entire article, you can just read what Dr. Christiane Neubaur, managing director of Verband der Cannabis versorgenden Apotheken (VCA) has said about the above. Dr. Christiane Neubaur, managing director of Verband der Cannabis versorgenden Apotheken (VCA), wrote on LinkedIn: "Many patients who currently receive prescription cannabis medicine do not fall under these approved indications." https://cannabishealthnews.co.uk/2026/07/14/germany-bans-medical-cannabis-flower-from-reimbursement-and-mandates-six-month-trial-for-extracts/I repeat again, again and gladly do it again. The people who have been in a treatment course with Cannabis flowers are beyond the 6 months because they HAVE been in a treatment course with cannabis flowers. The people who have received a prescription for cannabis flowers, but who are not documented as ill, they lose the subsidy and must pay themselves. The people who will be affected, i.e., that they have to wait 6 months before they can get a prescription for ex. Weeco Astrum 10/10, are those who are just entering the treatment system now. Everyone else who has been in treatment systems has completed the 6-month quarantine. The above is the direct reason why we can state today that several pharmacies have received Weeco Astrum 10/10 in stock. As well as we will also see online stores that currently only have flower medicine in their assortment also getting oils and extracts. Either you can scroll down and read what I have written about spin and that it's not about people losing their subsidy. It's only about many people losing a lot of money because flower medicine loses the subsidy, or you can start digging yourself into what is actually happening in Germany.
- ·3 päivää sittenStock status Can One Stop has gone from 3 to 5 pharmacies that have Weeco Astrum 10/10 permanently in stock. They still send to the remaining pharmacies, 519 pharmacies, with which they have a collaboration. Green Medical has gone from 3 to 5 pharmacies. Green Medical sends to these 5 pharmacies and to private addresses. Weed.de has gone from 3 to 7 pharmacies Weed.de also sends to private addresses. Canngo has gone from 4 to 6 pharmacies Canngo also sends the oil to private addresses. Flowzz has gone from 3 to 5 pharmacies. Flowzz also sends the oil to private addresses. It seems that Weeco Pharma's campaign for Weeco Astrum 10/10 is working. As well as that doctors also, gradually, have started to find alternatives to flower medicine.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt